Sentinel Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-49,327
Closed -$1.39M 233
2016
Q1
$1.39M Buy
49,327
+23,188
+89% +$662K 0.03% 198
2015
Q4
$801K Hold
26,139
0.02% 203
2015
Q3
$779K Hold
26,139
0.02% 210
2015
Q2
$832K Hold
26,139
0.02% 223
2015
Q1
$863K Sell
26,139
-196,044
-88% -$6.23M 0.02% 227
2014
Q4
$6.57M Buy
222,183
+72,247
+48% +$2.07M 0.14% 170
2014
Q3
$4.21M Sell
149,936
-913,290
-86% -$25.6M 0.09% 195
2014
Q2
$29.9M Sell
1,063,226
-316,200
-23% -$9.01M 0.6% 60
2014
Q1
$42M Hold
1,379,426
0.83% 25
2013
Q4
$40.1M Sell
1,379,426
-3,162
-0.2% -$92K 0.78% 25
2013
Q3
$37.7M Buy
1,382,588
+44,051
+3% +$1.2M 0.79% 20
2013
Q2
$35.6M Buy
+1,338,537
New +$37M 0.77% 21

Other funds holding PFE

Sentinel Asset Management's PFE Position: Q2 2016 in Review

Sentinel Asset Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 49,327 shares — an estimated $1.39M sold.

Sentinel Asset Management first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $42M in Q1 2014. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Sentinel Asset Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Sentinel Asset Management sold 49,327 Pfizer shares in Q2 2016, an estimated $1.39M.
  • Sentinel Asset Management first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
  • Sentinel Asset Management's Pfizer position peaked at $42M in Q1 2014.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Sentinel Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.